In: Pharmaceuticals
What You Cared About in 2017
This past year was filled with just as many “Woah, that’s awesome” moments as “Wait, is this actually happening?” ones. Through…
Read MoreSelecting the Right Investment Bank to Take Your Company Public
Taking a company public is a momentous milestone in the growth of a life science or healthcare company. Whether or not…
Read MoreiBIO IndEx 2017: Amid Political Uncertainty, Industry Collaboration Is Key to Advancement
The effects of technological advances and an uncertain political environment were the focus of this year’s Illinois Biotechnology Innovation Organization (iBIO)…
Read MoreGene Editing with CRISPR Technology: Keeping the Focus on Patients
Ever since a proof-of-concept paper was published in 2012, the gene-editing technique CRISPR-Cas9 has been making waves as a major scientific…
Read MoreGlobal Science Marketing: Expanding Your Presence Across the Globe
With online communities and communication across labs increasing, science companies find themselves crossing national borders to establish an international presence. There…
Read MoreA Bright Future for Pharma and Biotech in 2016
Before 2016 even officially kicked off, the life sciences industry received an early present to the tune of $32 billion. The…
Read MoreWhat You Cared About in 2015
As the year closes, one can’t help but reflect. So, we take a look back at our most popular blog posts…
Read MoreThe Drug Development Process: A Rube Goldberg of Life Sciences?
A Rube Goldberg contraption is an over-engineered machine that uses chain reactions to accomplish the simplest of tasks in the most…
Read MoreMassachusetts Paves the Way for Rare Disease and Orphan Drug Development
A recent article in the Boston Business Journal has revealed the full extent of the Bay State’s booming rare disease research…
Read MoreAnimal Biotechnology Part Two: Advances in the Veterinary Space
As we learned in part one of this series, the field of animal biotechnology consists of two main arms of research….
Read More